Order and disorder in the magnetisation of the chiral crystal CrNb3S6

Competing magnetic anisotropies in chiral crystals with Dzyaloshinskii-Moriya exchange interactions can give rise to nontrivial chiral topological magnetization configurations with new and interesting properties. One such configuration is the magnetic soliton, where the moment continuously rotates about an axis. This magnetic system can be considered to be one dimensional and, because of this, it supports a macroscale coherent magnetization, giving rise to a tunable chiral soliton lattice (CSL) that is of potential use in a number of applications in nanomagnetism and spintronics. In this paper, we characterize the transitions between the forced-ferromagnetic (F-FM) phase and the CSL one in CrNb3S6 using differential phase contrast imaging in a scanning transmission electron microscope, conventional Fresnel imaging, ferromagnetic resonance spectroscopy, and mean-field modeling. We find that the formation and movement of dislocations mediate the formation of CSL and F-FM regions and that these strongly influence the highly hysteretic static and dynamic properties of the system. Sample size and morphology can be used to tailor the properties of the system and, with the application of magnetic field, to locate and stabilize normally unstable dislocations and modify their dimensions and magnetic configurations in ways beyond that predicted to occur in uniform films

DNA Methylation Profiles of the Brain-Derived Neurotrophic Factor (BDNF) Gene as a Potent Diagnostic Biomarker in Major Depression

Major depression, because of its recurring and life-threatening nature, is one of the top 10 diseases for global disease burden. Major depression is still diagnosed on the basis of clinical symptoms in patients. The search for specific biological markers is of great importance to advance the method of diagnosis for depression. We examined the methylation profile of 2 CpG islands (I and IV) at the promoters of the brain-derived neurotrophic factor (BDNF) gene, which is well known to be involved in the pathophysiology of depression. We analyzed genomic DNA from peripheral blood of 20 Japanese patients with major depression and 18 healthy controls to identify an appropriate epigenetic biomarker to aid in the establishment of an objective system for the diagnosis of depression. Methylation rates at each CpG unit was measured using a MassArray (R) system (SEQUENOM), and 2-dimensional hierarchical clustering analyses were undertaken to determine the validity of these methylation profiles as a diagnostic biomarker. Analyses of the dendrogram from methylation profiles of CpG I, but not IV, demonstrated that classification of healthy controls and patients at the first branch completely matched the clinical diagnosis. Despite the small number of subjects, our results indicate that classification based on the DNA methylation profiles of CpG I of the BDNF gene may be a valuable diagnostic biomarker for major depression